Published in J Virol on August 01, 2005
Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol (2007) 1.61
Role of free radicals in liver diseases. Hepatol Int (2009) 1.36
Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol (2006) 1.31
HCV and oxidative stress in the liver. Viruses (2013) 1.28
Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex. J Gen Virol (2011) 1.20
Early blood profiles of virus infection in a monkey model for Lassa fever. J Virol (2007) 1.20
Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol (2007) 1.19
Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci U S A (2014) 1.11
Hepatitis C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy. PLoS Pathog (2013) 1.07
RNA Viruses: ROS-Mediated Cell Death. Int J Cell Biol (2014) 1.01
Does oxidative stress participate in the development of hepatocellular carcinoma? J Gastroenterol (2007) 0.94
Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network. Genes Nutr (2012) 0.89
Oncogenic viruses and tumor glucose metabolism: like kids in a candy store. Mol Cancer Ther (2012) 0.89
Phosphoinositides in the hepatitis C virus life cycle. Viruses (2012) 0.86
Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones. BMC Genomics (2008) 0.85
Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma. MedGenMed (2007) 0.85
Infection of human endothelial cells with spotted Fever group rickettsiae stimulates cyclooxygenase 2 expression and release of vasoactive prostaglandins. Infect Immun (2006) 0.82
Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family. PLoS One (2016) 0.79
Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients. Clin Exp Immunol (2015) 0.79
Betulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-κB- and MAPK-ERK1/2-mediated COX-2 expression. Br J Pharmacol (2015) 0.79
Induction of omega 6 inflammatory pathway by sodium metabisulfite in rat liver and its attenuation by ghrelin. Lipids Health Dis (2015) 0.78
Inhibition of neutral sphingomyelinase decreases arachidonic acid mediated inflammation in liver ischemia-reperfusion injury. Int J Clin Exp Pathol (2014) 0.78
Interplay between Hepatitis C Virus and Redox Cell Signaling. Int J Mol Sci (2013) 0.78
Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies. World J Gastroenterol (2014) 0.78
Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway. Immunology (2016) 0.77
The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism. J Biol Chem (2015) 0.77
HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway. PLoS One (2015) 0.77
Mitochondrial complex III deficiency in a case of HCV related noninflammatory myopathy. J Neurol (2007) 0.76
Small molecule inhibitors of HCV replication from pomegranate. Sci Rep (2014) 0.76
Overexpression of cyclooxygenase-2 and transforming growth factor-beta 1 is an independent predictor of poor virological response to interferon therapy in chronic HCV genotype 4 patients. Saudi J Gastroenterol (2014) 0.76
Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus. Virology (2012) 0.75
Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features. Clinics (Sao Paulo) (2016) 0.75
Analysis of polyunsaturated fatty acids and the omega-6 inflammatory pathway in hepatic ischemia/re-perfusion injury. Mol Med Rep (2015) 0.75
Gallic acid decreases hepatitis C virus expression through its antioxidant capacity. Exp Ther Med (2015) 0.75
Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol (1987) 26.70
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (1999) 24.31
Efficient initiation of HCV RNA replication in cell culture. Science (2000) 15.12
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J (1991) 11.86
NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer (2002) 11.39
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell (1995) 6.69
Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol (2001) 6.37
Effect of alpha interferon on the hepatitis C virus replicon. J Virol (2001) 6.18
Replication of hepatitis C virus. J Gen Virol (2000) 6.08
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest (2001) 5.87
The role of cyclooxygenases in inflammation, cancer, and development. Oncogene (1999) 5.50
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (1997) 5.43
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer (2001) 4.62
Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res (1995) 4.52
Phosphoinositide 3-kinase signalling pathways. J Cell Sci (2001) 3.24
Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A (2001) 3.06
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol (2003) 2.86
Hepatitis C and hepatocellular carcinoma. Hepatology (1997) 2.83
A novel sequence found at the 3' terminus of hepatitis C virus genome. Biochem Biophys Res Commun (1995) 2.58
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res (1999) 2.40
Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol (2002) 2.39
A new view of prostaglandin E regulation of the immune response. Immunol Today (1991) 2.36
Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med (1990) 2.35
The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem (2000) 2.28
Novel cell culture systems for the hepatitis C virus. Antiviral Res (2001) 2.26
Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol (2005) 2.14
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res (2001) 2.07
Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res (2000) 2.05
Eicosanoids and the gastrointestinal tract. Gastroenterology (1995) 2.04
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J (2001) 2.03
The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J Gen Virol (2004) 2.02
Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes (2003) 1.91
Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A (2002) 1.77
Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology (2004) 1.71
Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol (2002) 1.71
Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res (2001) 1.64
Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology (2003) 1.61
The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem (2004) 1.60
Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol (2001) 1.56
The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest (2002) 1.55
An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem (2000) 1.52
The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev (2000) 1.52
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (2000) 1.51
Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J Biol Chem (2003) 1.45
Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol (2002) 1.44
Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol (2005) 1.39
Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer (2000) 1.39
The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta ) and C/EBP delta transcription factors. J Biol Chem (2001) 1.39
Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology (2002) 1.35
Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem (2000) 1.31
Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem Pharmacol (2002) 1.27
The role and regulation of COX-2 during viral infection. Viral Immunol (2003) 1.20
COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs (2002) 1.10
Antiviral activity of cyclopentenone prostanoids. Trends Microbiol (1997) 1.02
Prostaglandin E2 inhibits apoptosis in human neutrophilic polymorphonuclear leukocytes: role of intracellular cyclic AMP levels. Exp Hematol (1998) 1.01
Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy. Aliment Pharmacol Ther (2002) 0.99
COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression. J Virol (2003) 0.98
Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surg Oncol (1998) 0.97
Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection. J Immunol (2003) 0.96
Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase. Cardiovasc Res (2003) 0.96
Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production. J Oral Pathol Med (2001) 0.93
Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell Immunol (2002) 0.92
Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA (2004) 0.87
Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Radic Biol Med (1992) 0.85
Constitutive expression of the cyclooxygenase-2 gene in T-cell lines infected with human T cell leukemia virus type I. Int J Cancer (2001) 0.85
Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation (1994) 0.82
Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C. J Viral Hepat (1999) 0.79
Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated WISH cells. Arch Virol (1975) 0.79
Relationship between the prostaglandin cascade and virus infection. Acta Virol (1990) 0.77
Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol (2002) 2.39
Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. J Biol Chem (2004) 2.29
Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol (2005) 2.14
Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab (2009) 2.05
Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol (2007) 1.61
Cell-free replication of the hepatitis C virus subgenomic replicon. J Virol (2002) 1.52
Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J Biol Chem (2003) 1.45
Role of oxysterol binding protein in hepatitis C virus infection. J Virol (2009) 1.43
Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol (2005) 1.39
Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion. J Biol Chem (2005) 1.30
Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem Pharmacol (2002) 1.27
Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication. Virology (2005) 1.24
Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol (2007) 1.19
Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J Virol (2002) 1.18
Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion. J Biol Chem (2012) 1.15
Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci U S A (2014) 1.11
Hepatitis C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy. PLoS Pathog (2013) 1.07
Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells. J Virol (2003) 1.04
Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein. J Biol Chem (2011) 1.02
Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathog (2013) 1.00
Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus. Hepatology (2011) 1.00
Characterization of the mitochondrial association of hepatitis B virus X protein, HBx. Mitochondrion (2002) 0.98
Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J Virol (2007) 0.94
Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. J Virol (2013) 0.90
Neuropsychology of prefrontal cortex. Indian J Psychiatry (2008) 0.89
Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors. J Med Chem (2005) 0.88
Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA (2004) 0.87
Diode-pumped, high-average-power femtosecond Cr3+ :LiCAF laser. Opt Lett (2007) 0.87
Phosphoinositides in the hepatitis C virus life cycle. Viruses (2012) 0.86
Technical standards for hepatitis B virus X protein (HBx) research. Hepatology (2015) 0.86
Generation of 287 W, 5.5 ps pulses at 78 MHz repetition rate from a cryogenically cooled Yb:YAG amplifier seeded by a fiber chirped-pulse amplification system. Opt Lett (2008) 0.85
Bipolar affective disorder associated with thenar hypoplasia: is lithium safe? Am J Ther (2010) 0.76
130-W picosecond green laser based on a frequency-doubled hybrid cryogenic Yb:YAG amplifier. Opt Express (2009) 0.75
[The effect of Hepatitis C virus nonstructural protein 5A on cell cycling]. Zhonghua Gan Zang Bing Za Zhi (2004) 0.75
Investigation of a Solid-State Tuning Behavior in Lithium Niobate. IEEE Trans Ultrason Ferroelectr Freq Control (2019) 0.75